Asynchronous Telemedicine for Isotretinoin Management: A Direct Care Pilot
January 2021
in “
Journal of the American Academy of Dermatology
”
TLDR Asynchronous telemedicine for acne treatment is effective and improves access and productivity.
During the COVID-19 pandemic, a pilot program for asynchronous telemedicine (AT) was implemented for isotretinoin management in acne patients at an urban dermatology clinic. The study involved 126 patients who completed 182 AT visits, compared to 17 synchronous telemedicine (ST) visits. The AT program allowed patients to upload photos and complete questionnaires online, with physicians responding asynchronously. Results showed no significant difference in dosing outcomes between AT and ST groups, indicating that dermatologists were comfortable adjusting isotretinoin doses remotely. The program also aligned pregnancy testing with clinical encounters, overcoming administrative burdens. Despite the lack of insurance reimbursement for AT, the study suggested that AT could enhance patient access and clinical productivity, urging further adoption of teledermatology practices.